Stenvinkel P - Search Results

1

Inflammation and gut dysbiosis as drivers of CKD-MBD.

Evenepoel P, Stenvinkel P, Shanahan C, Pacifici R. Evenepoel P, et al. Among authors: stenvinkel p. Nat Rev Nephrol. 2023 Oct;19(10):646-657. doi: 10.1038/s41581-023-00736-7. Epub 2023 Jul 24. Nat Rev Nephrol. 2023. PMID: 37488276 Review.

2

Genetic and clinical factors influence the baseline permeability of the peritoneal membrane.

Gillerot G, Goffin E, Michel C, Evenepoel P, Biesen WV, Tintillier M, Stenvinkel P, Heimbürger O, Lindholm B, Nordfors L, Robert A, Devuyst O. Gillerot G, et al. Among authors: stenvinkel p. Kidney Int. 2005 Jun;67(6):2477-87. doi: 10.1111/j.1523-1755.2005.00357.x. Kidney Int. 2005. PMID: 15882295 Free article.

3

Predialysis chronic kidney disease in 2010: Novel targets for slowing CKD progression.

Carrero JJ, Stenvinkel P. Carrero JJ, et al. Among authors: stenvinkel p. Nat Rev Nephrol. 2011 Feb;7(2):65-6. doi: 10.1038/nrneph.2010.177. Nat Rev Nephrol. 2011. PMID: 21278712 Review.

4

Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD.

Haarhaus M, Brandenburg V, Kalantar-Zadeh K, Stenvinkel P, Magnusson P. Haarhaus M, et al. Among authors: stenvinkel p. Nat Rev Nephrol. 2017 Jul;13(7):429-442. doi: 10.1038/nrneph.2017.60. Epub 2017 May 15. Nat Rev Nephrol. 2017. PMID: 28502983 Review.

5

Sclerostin─A Debutant on the Autosomal Dominant Polycystic Kidney Disease Scene?

Jankowska M, Haarhaus M, Qureshi AR, Lindholm B, Evenepoel P, Stenvinkel P. Jankowska M, et al. Among authors: stenvinkel p. Kidney Int Rep. 2017 Jan 10;2(3):481-485. doi: 10.1016/j.ekir.2017.01.001. eCollection 2017 May. Kidney Int Rep. 2017. PMID: 29142975 Free PMC article.

6

A distinct bone phenotype in ADPKD patients with end-stage renal disease.

Evenepoel P, Claes K, Cavalier E, Meijers B, Stenvinkel P, Behets G, Jankowska M, D'Haese P, Bammens B. Evenepoel P, et al. Among authors: stenvinkel p. Kidney Int. 2019 Feb;95(2):412-419. doi: 10.1016/j.kint.2018.09.018. Kidney Int. 2019. PMID: 30665572 Free article.

7

Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients.

Fourdinier O, Schepers E, Metzinger-Le Meuth V, Glorieux G, Liabeuf S, Verbeke F, Vanholder R, Brigant B, Pletinck A, Diouf M, Burtey S, Choukroun G, Massy ZA, Metzinger L; European Uremic Toxin Work Group-EUTox. Fourdinier O, et al. Sci Rep. 2019 Mar 14;9(1):4477. doi: 10.1038/s41598-019-41101-8. Sci Rep. 2019. PMID: 30872798 Free PMC article.

8

Matrix Gla protein is an independent predictor of both intimal and medial vascular calcification in chronic kidney disease.

Jaminon AMG, Dai L, Qureshi AR, Evenepoel P, Ripsweden J, Söderberg M, Witasp A, Olauson H, Schurgers LJ, Stenvinkel P. Jaminon AMG, et al. Among authors: stenvinkel p. Sci Rep. 2020 Apr 20;10(1):6586. doi: 10.1038/s41598-020-63013-8. Sci Rep. 2020. PMID: 32313061 Free PMC article.

9

Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug-Bug Interaction?

Dai L, Meijers BK, Bammens B, de Loor H, Schurgers LJ, Qureshi AR, Stenvinkel P, Evenepoel P. Dai L, et al. Among authors: stenvinkel p. Toxins (Basel). 2020 May 27;12(6):351. doi: 10.3390/toxins12060351. Toxins (Basel). 2020. PMID: 32471179 Free PMC article.

10

Food as medicine: targeting the uraemic phenotype in chronic kidney disease.

Mafra D, Borges NA, Lindholm B, Shiels PG, Evenepoel P, Stenvinkel P. Mafra D, et al. Among authors: stenvinkel p. Nat Rev Nephrol. 2021 Mar;17(3):153-171. doi: 10.1038/s41581-020-00345-8. Epub 2020 Sep 22. Nat Rev Nephrol. 2021. PMID: 32963366 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

682 results

Search Page

Filters